An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia

NCT02234583 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2485

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain Associated With Fibromyalgia

Interventions

DRUG: DS-5565

Sponsor

Daiichi Sankyo